%s1 / %s2

Playlist: Sunvalley Communication, LLC

Compiled By: Peter Hofland

No text

The OncoZine Brief (Series)

Produced by Peter Hofland

Most recent piece in this series:

SU2C: Engaging the Public in Supporting Cancer Research

From Peter Hofland | Part of the The OncoZine Brief series | 40:47


In this edition of The Onco’Zine Brief co-hosts Peter Hofland and Shelly Reynolds talk with a number of medical scientists, physicians, experts, patient advocates and celebrities who attended the live telecast on Friday, September 7, 2018 in Santa Monica, California.

The Onco’Zine Brief was there and the team had the opportunity to ask a number of physicians, celebrities, cancer survivors and advocates why they support Stand-Up-2-Cancer and what SU2C has accomplished since the founding of the organization in 2008. Now 10 years old, Stand-Up-2-Cancer, a division of the Entertainment Industry Foundation, was founded in 2008 by media and entertainment leaders who used their resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention and to highlight progress being made in the fight against the disease.

The founders of the organization were convinced that the war against cancer, which started with the signing of the National Cancer Act on December 23, 1971 by President Richard Nixon, was at a tipping point.

Based on breakthroughs made in the understanding of the basic science and the biology of cancer, as well as technological advances enabling this increased understanding to be translated into new treatments, these founders strongly believed that cancer research was indeed at a pivotal juncture where transformative progress would ultimately help cancer patients.

But they also understood that cancer researchers needed additional funding to fulfill the promise of the development of these life-saving discoveries.

And that’s where Stand-Up-2-Cancer engaged in securing public support for the work of cancer research in the United States and around the world.

Over the last decade, this unique initiative has shown impressive results. To date, more than US $ 603 million has been pledged in support of Stand-Up-2-Cancer ground-breaking cancer research programs. The result is that, as of April 2018, more than 1,500 scientists, from different disciplines and representing more than 180 institutions, work collaboratively in research-projects funded by Stand-Up-2-Cancer.

The funds the organization raises are especially earmarked to accelerate the pace of research and to get new therapies to patients quickly and, as a direct result, save lives now. As part of their approach, Stand-Up-2-Cancer engages the public in supporting a new, collaborative model of cancer research.

They also increase awareness about cancer prevention as well as progress being made in the fight against this disease. The organization’s scientific partner is the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Dr. Phillip Sharp. The scientific team conducts a rigorous review to identify the best research proposals to recommend for funding. They also oversee grants administration, and provide expert review of research progress.

Stand-Up-To Cancer-funded researchers have planned, launched or completed more than 180 clinical trials involving over 12,000 patients. And collectively, work by these scientists has contributed to the approval by the United States Food and Drug Administration – or FDA - of five new cancer treatments.

The sixth biennial one-hour “Roadblock” fundraising telecast of Stand-Up-To-Cancer aired live from The Barker Hangar in Santa Monica, CA on Friday, September 7, 2018. The program aired on more than 70 broadcast and cable networks and streaming and social media platforms, all of which donated one hour of simultaneous commercial-free prime-time for the entire Stand-Up-To-Cancer telecast.

This year, for the first time ever, the show was preceded by a digital live show "It's #Up2Us: Stand Up To Cancer | The Digital Live Show" in which social media platforms Facebook, Twitter and YouTube united for a one-hour standalone digital show.

And the show, as well as it’s digital counterpart, was a success. On Sunday, September 9, 2018 the organization announced the initial results of pledges made up to then. And "… with more than $123.6 million pledged, this was the best-ever fundraising special for Stand-Up-To Cancer."